ANI PHARMACEUTICALS INC - COM (ANIP)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
18.9M
Holdings value Q3 2024
$1.13B
Value change Q3 2024
+$221M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
207
Number of buys Q3 2024
122
Number of sells Q3 2024
-73
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 18.9M $1.13B +$221M $59.66 207
2024 Q2 15.1M $963M +$64.6M $63.68 200
2024 Q1 14.1M $974M +$37.3M $69.13 196
2023 Q4 13.6M $750M +$15M $55.14 179
2023 Q3 13.2M $765M +$52.1M $58.06 184
2023 Q2 12.3M $661M +$105M $53.83 168
2023 Q1 10.3M $411M +$7.05M $39.72 136
2022 Q4 10.2M $412M +$2.76M $40.23 125
2022 Q3 10.3M $330M +$12.8M $32.14 114
2022 Q2 9.86M $293M +$29.9M $29.67 108
2022 Q1 9.19M $258M -$5.75M $28.11 115
2021 Q4 8.96M $413M +$77.7M $46.08 127
2021 Q3 7.28M $239M +$14.2M $32.82 104
2021 Q2 7.2M $252M -$2.87M $35.05 104
2021 Q1 7.29M $263M +$392K $36.14 101
2020 Q4 7.36M $214M +$3.09M $29.04 111
2020 Q3 7.27M $205M -$6.3M $28.21 105
2020 Q2 7.43M $240M -$25.7M $32.34 123
2020 Q1 7.94M $323M -$12.4M $40.74 135
2019 Q4 8.07M $498M -$71.1M $61.67 162
2019 Q3 9.1M $663M +$37.9M $72.88 185
2019 Q2 8.56M $704M +$78.9M $82.20 191
2019 Q1 7.7M $543M +$45.4M $70.54 182
2018 Q4 7.08M $319M -$18.3M $45.02 159
2018 Q3 7.5M $424M +$15.4M $56.54 166
2018 Q2 7.19M $480M +$39.8M $66.80 182
2018 Q1 6.62M $386M +$5.07M $58.22 170
2017 Q4 6.54M $422M +$7.86M $64.45 154
2017 Q3 6.41M $337M -$1.06M $52.49 138
2017 Q2 6.49M $305M +$671K $46.80 144
2017 Q1 6.44M $319M +$59.7M $49.51 150
2016 Q4 6.25M $379M +$12.8M $60.62 150
2016 Q3 5.99M $397M +$26.7M $66.35 165
2016 Q2 5.61M $313M +$11.6M $55.82 135
2016 Q1 5.81M $195M -$21.5M $33.66 115
2015 Q4 6.32M $285M -$31.1M $45.12 119
2015 Q3 6.97M $275M +$17M $39.51 118
2015 Q2 6.49M $403M -$29.2M $62.05 120
2015 Q1 6.96M $435M +$84.6M $62.55 127
2014 Q4 5.63M $317M +$97.1M $56.39 99
2014 Q3 4.53M $129M -$3.21M $28.28 69
2014 Q2 4.55M $156M +$28.4M $34.44 79
2014 Q1 3.76M $118M +$77.6M $31.35 64